ASX:MYX

Mayne Pharma Group Limited (MYX.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$0.43

MA: A$0.43▼

A$0.43

52-Week Range N/A

Volume5.47 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Korea, and internationally. The company operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Overall MarketRank^™

0.54 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Mayne Pharma Group Limited (MYX.AX).

2.7 Community Rank

Outperform Votes
Mayne Pharma Group Limited (MYX.AX) has received 63 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Mayne Pharma Group Limited (MYX.AX) has received 53 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Mayne Pharma Group Limited (MYX.AX) has received 54.31% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Mayne Pharma Group Limited (MYX.AX) and other stocks. Vote “Outperform” if you believe MYX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MYX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Mayne Pharma Group Limited (MYX.AX) does not currently pay a dividend.
Dividend Growth
Mayne Pharma Group Limited (MYX.AX) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Mayne Pharma Group Limited (MYX.AX) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolASX:MYX

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.maynepharma.com

Phone+61-8-82092666

EmployeesN/A

Debt

Debt-to-Equity Ratio38.52

Current Ratio2.24

Quick Ratio1.69

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$456.98 million

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow7.20

Book ValueA$0.62 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive MYX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

Mayne Pharma Group Limited (MYX.AX) (ASX:MYX) Frequently Asked Questions

What stocks does MarketBeat like better than Mayne Pharma Group Limited (MYX.AX)?

Wall Street analysts have given Mayne Pharma Group Limited (MYX.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mayne Pharma Group Limited (MYX.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Mayne Pharma Group Limited (MYX.AX)'s next earnings date?

Mayne Pharma Group Limited (MYX.AX) is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Mayne Pharma Group Limited (MYX.AX).

How were Mayne Pharma Group Limited (MYX.AX)'s earnings last quarter?

Mayne Pharma Group Limited (MYX.AX) (ASX:MYX) posted its quarterly earnings data on Friday, February, 22nd. The company reported $0.02 earnings per share for the quarter.
View Mayne Pharma Group Limited (MYX.AX)'s earnings history.

Who are some of Mayne Pharma Group Limited (MYX.AX)'s key competitors?

Some companies that are related to Mayne Pharma Group Limited (MYX.AX) include Antisense Therapeutics Limited (ANP.AX) (ANP), Bayer Aktiengesellschaft (BAYN.F) (BAYN), Mayne Pharma Group (MAYNF), Medical Developments International Limited (MVP.AX) (MVP), Opthea Limited (OPT.AX) (OPT), Otsuka (OTSKY), Patrys Limited (PAB.AX) (PAB), Pharmaxis Ltd (PXS.AX) (PXS), Recce Pharmaceuticals Ltd (RCE.AX) (RCE), Roche (RHHVF), Sanofi (SAN.PA) (SAN), Sinclair Pharma plc (SPH.L) (SPH) and Vita Life Sciences Limited (VLS.AX) (VLS).
View all of MYX's competitors.

What other stocks do shareholders of Mayne Pharma Group Limited (MYX.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mayne Pharma Group Limited (MYX.AX) investors own include Sundance Energy (SNDE), Aurora Cannabis (ACB), Turquoise Hill Resources (TRQ), Telstra Co. Limited (TLS.AX) (TLS), The Green Organic Dutchman (TGODF), Perseus Mining Limited (PRU.AX) (PRU), OrganiGram (OGI), Karoon Energy Ltd (KAR.AX) (KAR), Crown Resorts Limited (CWN.AX) (CWN) and Cronos Group (CRON).

Who are Mayne Pharma Group Limited (MYX.AX)'s key executives?

Mayne Pharma Group Limited (MYX.AX)'s management team includes the following people:

Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 56, Pay $1.47M)
Mr. Peter Paltoglou, Chief Financial Officer
Mr. Stefan J. Cross, Pres of International Operations (Age 47)
Ms. Lisa Pendlebury, VP of Investor Relations & Communications
Ms. Kate Rintoul, Exec. VP & Gen. Counsel
Dr. Andrew O. Herdman Ph.D., VP of Group HR
Mr. Brant Schofield, Exec. VP of Specialty Brands Division (Age 54)
Mr. Daniel Moore, Exec. VP of Generics Products Division
Mr. Brenton Walter, Financial Controller
Mr. John S. Ross, Pres of Mayne Pharma USA

What is Mayne Pharma Group Limited (MYX.AX)'s stock symbol?

Mayne Pharma Group Limited (MYX.AX) trades on the ASX under the ticker symbol "MYX."

How big of a company is Mayne Pharma Group Limited (MYX.AX)?

Mayne Pharma Group Limited (MYX.AX) has a market capitalization of $0.00 and generates $456.98 million in revenue each year. Mayne Pharma Group Limited (MYX.AX) employs 780 workers across the globe.

What is Mayne Pharma Group Limited (MYX.AX)'s official website?

The official website for Mayne Pharma Group Limited (MYX.AX) is www.maynepharma.com.

How can I contact Mayne Pharma Group Limited (MYX.AX)?

Mayne Pharma Group Limited (MYX.AX)'s mailing address is 1538 Main North Rd, ADELAIDE, SA 5106, Australia. The company can be reached via phone at +61-8-82092666.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Mayne Pharma Group Limited (MYX.AX) Stock Forecast, Price & News

Adding